Vitadio
Pioneering prescription digital therapeutics
Vitadio is a company focused on pioneering prescription digital therapeutics by reversing insulin resistance using AI-driven lifestyle modification.
Our purpose
Our purpose is empowering people to restore their cardiometabolic health. We create digital therapies that treat the cause, not the symptoms, one habit at a time, without side effects. The first digital therapy for type 2 diabetes is covered by all statutory health insurers in Germany.
Robust DTx platform with a human touch
Our platform offers personalised therapy by building healthy habits through smart nudges and personalised goals. We combine evidence-based content and complex user data to provide daily engaging guidance.
We provide AI-driven real-time feedback through a proprietary AI model that offers diet feedback and recommendations akin to a human dietitian anytime and anywhere.
Users receive proactive human support through sharing experiences in an in-app social network or via a personal dietitian.
Clinically proven outcomes
Vitadio's digital therapeutics show clinical effects comparable to modern antidiabetic drugs and have been rigorously validated in clinical studies. More patients achieved the recommended level of HbA1c and a significant portion report weight reduction.